Plenary Session III: Late-Breaking Clinical Trials Featured
8:30 AM - 10:00 AM
Saturday, January 15
The Late-Breaking Clinical Trial session emphasizes the most recent and groundbreaking research in the field of neuromodulation.
Welcome
Ellen L. Air, MD PhD; Nebojsa Nick Knezevic, MD PhD
Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy-18-Month Multicenter Randomized Controlled Trial Results (Abstract ID# 16457)
Erika Petersen, MD
Determining the Prognostic Value of Continuous Intrathecal Infusion (Abstract ID# 16264)
Bradford Jones, DO
The influence of stimulation frequency in DRG stimulation – a double-blind randomized trial (Abstract ID# 16240)
Guilherme Santos Piedade, MD
Twelve-month outcomes from RCT: 10kHz Spinal Cord Stimulation for treating Non-surgical Refractory Back Pain (Abstract ID# 16473)
Leonardo Kapural, MD PhD
Closing Q&A Discussion
John Markman, MD
Anuj Bhatia, MD PhD
Tagged under
Related items
- Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science
- Partnering with our Patients to Optimize Outcomes
- Neuromodulation and Neurosurgical Mentorship and Educational Development
- Controversies in Targeted Drug Delivery
- Spinal Cord Stimulation Mechanisms: Results from Animal Studies